Enhancing the safety and effectiveness of polyethylenimine gene delivery through cell membrane encapsulation

Mengying Wang,Yanlin Sun,Mingjie Wang,Zhaojun Yang,Yong Shi,Dong Zeng,Liang Liu
DOI: https://doi.org/10.1016/j.jddst.2024.105376
IF: 5
2024-01-14
Journal of Drug Delivery Science and Technology
Abstract:Due to the powerful DNA loading capacity and excellent proton sponge effect, the cationic polymer polyethyleneimine (PEI) has been demonstrated as a versatile, efficient DNA delivery tool both in vitro and in vivo. However, the excess surface positive charge of PEI and the common capture/clearance of PEI/DNA complex by the immune system limit its further clinical applications. To reduce the cytotoxicity resulting from surface charge and avoid the clearance of nanoparticles interacting with proteins and circulating immune cells in the blood, a bionic gene delivery system was developed by coating PEI/DNA complexes with natural cell membranes. The obtained RAW Cell membrane-coated PEI/DNA capsules (RAWm-PDc) and Red blood Cell membrane-coated PEI/DNA capsules (RBCm-PDc) complex showed excellent dispersibility and stability with an average particle size of 200–300 nm. Moreover, the RAWm-PDc/RBCm-PDc complex had great DNA loading capacity and protected the bound DNA effectively from nuclease hydrolysis. Most importantly, the RAWm-PDc/RBCm-PDc complex exhibited low protein adsorption, reduced cytotoxicity and high gene delivery efficiency. All the results demonstrated the potential of RAWm-PDc/RBCm-PDc as a promising non-viral gene delivery vector. Graphical abstract Download : Download high-res image (158KB) Download : Download full-size image
pharmacology & pharmacy
What problem does this paper attempt to address?
The main problem that this paper attempts to solve is to improve the safety and effectiveness of the polyethyleneimine (PEI) gene delivery system. Specifically, the researchers aim to solve several key problems in the existing PEI gene delivery system in the following ways: 1. **Reduce cytotoxicity**: Unmodified PEI has high cytotoxicity due to its excessive surface positive charge. This high cytotoxicity limits the further development of PEI in clinical applications. 2. **Avoid immune system clearance**: The PEI/DNA complex is easily captured and cleared by the immune system, which limits its stability and delivery efficiency in vivo. 3. **Enhance gene delivery efficiency**: Although the existing PEI gene delivery system has a strong DNA loading capacity and a good proton - sponge effect, in practical applications, its delivery efficiency still needs to be improved. To solve the above problems, the researchers developed a biomimetic gene delivery system. By using natural cell membranes (such as RAW cell membrane or red blood cell membrane) to coat the PEI/DNA complex, RAWm - PDc and RBCm - PDc complexes are formed. This method aims to: - **Reduce cytotoxicity**: By reducing the positive charge on the surface of PEI, thereby reducing the toxicity to cells. - **Avoid immune system recognition and clearance**: The cell membrane coating can mimic natural cells and avoid being recognized and cleared by the immune system. - **Improve gene delivery efficiency**: Ensure that DNA can effectively enter the target cells and be expressed, while protecting DNA from nuclease degradation. Through these improvements, the researchers hope to develop a safer and more efficient non - viral gene delivery vector to promote the development and application of gene therapy.